These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 24520544)
1. Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets. Dalamaga M World J Exp Med; 2013 Aug; 3(3):34-42. PubMed ID: 24520544 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges. Dalamaga M Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056 [TBL] [Abstract][Full Text] [Related]
3. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives. Christodoulatos GS; Spyrou N; Kadillari J; Psallida S; Dalamaga M Curr Obes Rep; 2019 Dec; 8(4):413-433. PubMed ID: 31637624 [TBL] [Abstract][Full Text] [Related]
4. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers. Assiri AM; Kamel HF; Hassanien MF Dis Markers; 2015; 2015():253519. PubMed ID: 25838618 [TBL] [Abstract][Full Text] [Related]
5. The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox. Karampela I; Christodoulatos GS; Dalamaga M Curr Obes Rep; 2019 Dec; 8(4):434-457. PubMed ID: 31637623 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer. Assiri AM; Kamel HF Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139 [TBL] [Abstract][Full Text] [Related]
7. Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies. Spyrou N; Avgerinos KI; Mantzoros CS; Dalamaga M Curr Obes Rep; 2018 Dec; 7(4):260-275. PubMed ID: 30145771 [TBL] [Abstract][Full Text] [Related]
8. Hormones of adipose tissue and their biologic role in lung cancer. Ntikoudi E; Kiagia M; Boura P; Syrigos KN Cancer Treat Rev; 2014 Feb; 40(1):22-30. PubMed ID: 23870486 [TBL] [Abstract][Full Text] [Related]
9. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Tilg H; Moschen AR Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136 [TBL] [Abstract][Full Text] [Related]
10. Adipose tissue, obesity and adipokines: role in cancer promotion. Booth A; Magnuson A; Fouts J; Foster M Horm Mol Biol Clin Investig; 2015 Jan; 21(1):57-74. PubMed ID: 25781552 [TBL] [Abstract][Full Text] [Related]
11. Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential. Wang YY; Hung AC; Lo S; Yuan SF Cancer Lett; 2021 Feb; 498():229-239. PubMed ID: 33152400 [TBL] [Abstract][Full Text] [Related]
12. Adipocytokines and Insulin Resistance: Their Role as Benign Breast Disease and Breast Cancer Risk Factors in a High-Prevalence Overweight-Obesity Group of Women over 40 Years Old. Sat-Muñoz D; Martínez-Herrera BE; Quiroga-Morales LA; Trujillo-Hernández B; González-Rodríguez JA; Gutiérrez-Rodríguez LX; Leal-Cortés CA; Portilla-de-Buen E; Rubio-Jurado B; Salazar-Páramo M; Gómez-Sánchez E; Delgadillo-Cristerna R; Carrillo-Nuñez GG; Nava-Zavala AH; Balderas-Peña LM Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627631 [TBL] [Abstract][Full Text] [Related]
13. Adipocytokines and breast cancer. Li J; Han X Curr Probl Cancer; 2018; 42(2):208-214. PubMed ID: 29433827 [TBL] [Abstract][Full Text] [Related]
14. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer. Rajesh Y; Sarkar D Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547 [TBL] [Abstract][Full Text] [Related]
15. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters. Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732 [TBL] [Abstract][Full Text] [Related]
16. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Chedraui P; Pérez-López FR; Escobar GS; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T; Maturitas; 2014 Sep; 79(1):86-90. PubMed ID: 25015014 [TBL] [Abstract][Full Text] [Related]
17. [Obesity and adipocytokines in breast cancer and benign breast disease]. Quiroga-Morales LA; Sat-Muñoz D; Martínez-Herrera BE; Alcántara-Cadillo RR; Macías-López GG; García-Cobián TA; Bañuelos-Rizo M; Balderas-Peña LMA Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):246-254. PubMed ID: 30376276 [TBL] [Abstract][Full Text] [Related]
18. Adipokines and epithelial-mesenchymal transition (EMT) in cancer. Akrida I; Papadaki H Mol Cell Biochem; 2023 Nov; 478(11):2419-2433. PubMed ID: 36715963 [TBL] [Abstract][Full Text] [Related]
19. Adipocytokines and the metabolic complications of obesity. Rasouli N; Kern PA J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272 [TBL] [Abstract][Full Text] [Related]
20. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]